These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 22127034)

  • 1. HIV infection and bone disease: implications for an aging population.
    Cotter AG; Mallon PW
    Sex Health; 2011 Dec; 8(4):493-501. PubMed ID: 22127034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-associated kidney disease in the context of an aging population.
    Naftalin C; Nathan B; Hamzah L; Post FA
    Sex Health; 2011 Dec; 8(4):485-92. PubMed ID: 22127033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine complications of human immunodeficiency virus infection: hypogonadism, bone disease and tenofovir-related toxicity.
    Cotter AG; Powderly WG
    Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):501-15. PubMed ID: 21663843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Life expectancy of HIV-positive adults: a review.
    May MT; Ingle SM
    Sex Health; 2011 Dec; 8(4):526-33. PubMed ID: 22127039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal antiretroviral therapy for aging.
    Cordery DV; Cooper DA
    Sex Health; 2011 Dec; 8(4):534-40. PubMed ID: 22127040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV and bone mineral density.
    Mallon PW
    Curr Opin Infect Dis; 2010 Feb; 23(1):1-8. PubMed ID: 20010102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV, cancer, and aging.
    Grulich AE; Jin F; Poynten IM; Vajdic CM
    Sex Health; 2011 Dec; 8(4):521-5. PubMed ID: 22127038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone disorders in human immunodeficiency virus infection.
    Glesby MJ
    Clin Infect Dis; 2003; 37 Suppl 2():S91-5. PubMed ID: 12942380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years.
    Bolland MJ; Grey AB; Horne AM; Briggs SE; Thomas MG; Ellis-Pegler RB; Woodhouse AF; Gamble GD; Reid IR
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):270-5. PubMed ID: 17547686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone health and human immunodeficiency virus infection.
    Schafer JJ; Manlangit K; Squires KE
    Pharmacotherapy; 2013 Jun; 33(6):665-82. PubMed ID: 23553497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of cardiovascular disease in HIV-infected patients.
    Das S
    J Antimicrob Chemother; 2010 Mar; 65(3):386-9. PubMed ID: 20026610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspective on HIV infection and aging: emerging research on the horizon.
    Casau NC
    Clin Infect Dis; 2005 Sep; 41(6):855-63. PubMed ID: 16107986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV infection and advanced age emerging epidemiological, clinical, and management issues.
    Manfredi R
    Ageing Res Rev; 2004 Jan; 3(1):31-54. PubMed ID: 15164725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone Disease in HIV: Recommendations for Screening and Management in the Older Patient.
    Hoy J
    Drugs Aging; 2015 Jul; 32(7):549-58. PubMed ID: 26123948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic options for low bone mineral density in HIV-infected subjects.
    Cotter AG; Mallon PW
    Curr HIV/AIDS Rep; 2012 Jun; 9(2):148-59. PubMed ID: 22528765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV infection, aging and cardiovascular disease: epidemiology and prevention.
    Petoumenos K; Worm SW
    Sex Health; 2011 Dec; 8(4):465-73. PubMed ID: 22127031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic bone disorders in HIV-infected patients: incidence in the Aquitaine cohort (1999-2002).
    Martin K; Lawson-Ayayi S; Miremont-Salamé G; Blaizeau MJ; Balestre E; Lacoste D; Ragnaud JM; Malvy D; Dupon M; Mercié P; Schaeverbeke T; Haramburu F; Dabis F;
    HIV Med; 2004 Nov; 5(6):421-6. PubMed ID: 15544694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of anitiretroviral therapy on bone tissue metabolism in patients with HIV].
    Olczak A; Pawłowska M; Drózdz W
    Przegl Epidemiol; 2008; 62(1):155-62. PubMed ID: 18536239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV, reproductive aging, and health implications in women: a literature review.
    Conde DM; Silva ET; Amaral WN; Finotti MF; Ferreira RG; Costa-Paiva L; Pinto-Neto AM
    Menopause; 2009; 16(1):199-213. PubMed ID: 18800017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
    McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
    AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.